Adherence to treatment and harmful effects of medication shortages in the context of severe crises: scale validation and correlates

dc.contributor.authorBou Malhab, Sandrella
dc.contributor.authorHaddad, Chadia
dc.contributor.authorSacre, Hala
dc.contributor.authorHajj, Aline
dc.contributor.authorZeenny, Rony M.
dc.contributor.authorAkel, Marwan G.
dc.contributor.authorSalameh, Pascale R.
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.departmentEpidemiology and Population Health (EPHD)
dc.contributor.departmentPharmacy
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:40:02Z
dc.date.available2025-01-24T11:40:02Z
dc.date.issued2023
dc.description.abstractBackground: Medication shortage is a public health problem, affecting patients’ outcomes mainly through the difficulty in maintaining adherence, particularly in the context of a severe economic crisis. There is a need for a new scale that assesses the effect of medication shortage on adherence. Aim: To develop and validate a scale to evaluate the harmful impact of medication shortage among the general Lebanese population and assess its correlates and association with medication adherence. Methods: A questionnaire was used to assess medication shortage harmful effects and patients’ adherence, allowing to generate the Harmful Impact of Medication Shortage scale (HIMS). The factor analysis, convergent validity and reliability of the generated scale were assessed, followed by multivariable regressions to evaluate its correlates. Results: The developed HIMS scale is a 9-item tool, used to assess how difficult it was for people to deal with medication shortages and their harmful effects on treatment. It was significantly and inversely linked to treatment adherence and affected by the patients’ socioeconomic status and the type of chronic disease. Conclusion: The Harmful Impact of Medication Shortage scale could be an efficient tool to measure the detrimental effects of medication shortages among the Lebanese adult population with chronic diseases, particularly affecting treatment adherence. Future studies and evidence are still needed to confirm our findings and help build global mitigation policies addressing medication shortages. © 2023, The Author(s).
dc.identifier.doihttps://doi.org/10.1186/s40545-023-00667-5
dc.identifier.eid2-s2.0-85178231071
dc.identifier.urihttp://hdl.handle.net/10938/29417
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.ispartofJournal of Pharmaceutical Policy and Practice
dc.sourceScopus
dc.subjectDrug shortage
dc.subjectFinancial crisis
dc.subjectManagement
dc.subjectMedication
dc.subjectValidation
dc.subjectAdult
dc.subjectArticle
dc.subjectChronic disease
dc.subjectCross-sectional study
dc.subjectFactor analysis
dc.subjectFemale
dc.subjectHuman
dc.subjectLebanese
dc.subjectMajor clinical study
dc.subjectMale
dc.subjectMedication compliance
dc.subjectMitigation
dc.subjectPatient compliance
dc.subjectPolicy
dc.subjectPopulation research
dc.subjectQuestionnaire
dc.subjectReliability
dc.subjectSocial status
dc.subjectValidation study
dc.titleAdherence to treatment and harmful effects of medication shortages in the context of severe crises: scale validation and correlates
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-277.pdf
Size:
1.27 MB
Format:
Adobe Portable Document Format